
HNGE Stock Forecast & Price Target
HNGE Analyst Ratings
Bulls say
Hinge Health Inc. has demonstrated a strong revenue growth trajectory, with an estimated 25% of annual growth in 2024 driven by improving yields, which are anticipated to continue increasing. The company’s current penetration rate of approximately 3.5% among eligible clients is significantly lower than the 9% penetration rate typical of traditional physical therapy, suggesting substantial room for growth. Furthermore, a history of elevated Net Revenue Retention (NRR) rates of 116-117% over the past two years, combined with a favorable outlook on new client acquisitions and programming enhancements, positions Hinge Health for continued revenue growth beyond consensus expectations.
Bears say
Hinge Health's financial outlook appears concerning due to its projected decline in EBIT margins, as management has guided to mid-teens EBIT margins for the second half of 2025, following a 19% margin in the second quarter of 2025. Consensus estimates for fiscal years 2026 and 2027 indicate EBIT margins of only 14.6% and 16.2%, respectively, which signal a weakening profitability trajectory. Such low margin forecasts may raise doubts regarding the company's ability to sustain competitive advantages and deliver strong financial performance in the future.
This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.
HNGE Analyst Forecast & Price Prediction
Start investing in HNGE
Order type
Buy in
Order amount
Est. shares
0 shares